Characteristics of patients and treatment episodes | All patients | Male | Female | P-valuea |
---|---|---|---|---|
Patients (n, %) | 3221 (100) | 2176 (67.6) | 1045 (32.4) | |
Age at treatment start (mean, SD) | 37.0 (6.7) | 37.7 (6.6) | 35.5 (6.6) | < 0.001 |
Age groups (n, %) | ||||
< 30 | 450 (14.0) | 254 (11.7) | 196 (18.8) | < 0.001 |
30-40 | 1797 (55.8) | 1185 (54.5) | 612 (58.6) | < 0.001 |
> 40 | 974 (30.2) | 737 (33.9) | 237 (22.7) | < 0.001 |
Continuous treatment (n, %) | 2046 (63.5) | 1391 (63.9) | 655 (62.7) | 0.492 |
Dropout (n, %) | 1175 (36.5) | 785 (36.1) | 390 (37.3) | 0.492 |
1 treatment episode | 660 (20.5) | 440 (20.2) | 220 (21.1) | 0.584 |
2 treatment episodes | 434 (13.5) | 294 (13.5) | 140 (13.4) | 0.929 |
3+ treatment episodes | 81 (2.5) | 51 (2.3) | 30 (2.3) | 0.371 |
Months in waiting-list, (median, SD) | 5.30 (11.78) | 5.49 (11.84) | 4.90 (11.65) | 0.099 |
Years in treatment, continuous (median, SD) | 1.97 (1.52) | 1.94 (1.52) | 2.05 (1.55) | 0.059 |
Years in treatment, drop out (median, SD) | 1.26 (1.28) | 1.22 (1.21) | 1.36 (1.39) | < 0.05 |
Months between treatment (median, range) b | 2.7 (0-51.9) | 3.2 (0-51.9) | 2.4 (0-50) | 0.187 |
Months after treatment (median, range) c | 13.1 (0-58.9) | 13.1 (0.2-58.9) | 13.2 (0-50.5) | 0.791 |